| Company Name: |
Bide Pharmatech Ltd.
|
| Tel: |
400-1647117 13681763483 |
| Email: |
product02@bidepharm.com |
| Products Intro: |
Product Name:2,4-Dioxo-N-[4-(pyridin-3-yloxy)phenyl]-1,2,3,4-tetrahydroquinazoline-6-sulfonamide
CAS:1214468-35-5
Purity:95% Package:50mg;100mg;250mg;1g Remarks:BD01051158
|
|
| | SIRT6-IN-1 Basic information |
| Product Name: | SIRT6-IN-1 | | Synonyms: | 1,2,3,4-Tetrahydro-2,4-dioxo-N-[4-(3-pyridinyloxy)phenyl]-6-quinazolinesulfonamide;2,4-dioxo-N-[4-(pyridin-3-yloxy)phenyl]-1,2,3,4-tetrahydroquinazoline-6-sulfonamide;SIRT6IN1,SIRT-6-IN-1,SIRT6 IN 1;6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-2,4-dioxo-N-[4-(3-pyridinyloxy)phenyl]-;bdbm50017341 | | CAS: | 1214468-35-5 | | MF: | C19H14N4O5S | | MW: | 410.4 | | EINECS: | | | Product Categories: | | | Mol File: | 1214468-35-5.mol |  |
| | SIRT6-IN-1 Chemical Properties |
| density | 1.496±0.06 g/cm3(Predicted) | | solubility | DMSO (Slightly) | | pka | 8.16±0.20(Predicted) | | form | Solid | | color | Red to Very Dark Brown |
| | SIRT6-IN-1 Usage And Synthesis |
| Uses | SIRT6-IN-1 is a novel SIRT6 inhibitor, with potential uses in treating in diabetes, immune-mediated disorders, and cancer. |
| | SIRT6-IN-1 Preparation Products And Raw materials |
|